Bacil Pharma Limited (BOM:524516)
India flag India · Delayed Price · Currency is INR
16.87
+0.07 (0.42%)
At close: Nov 16, 2026

Bacil Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
242685610863234
Market Cap Growth
-45.33%12.33%607.73%166.97%-4.36%83.65%
Enterprise Value
288669610832833
Last Close Price
16.7447.7342.4914.635.485.73

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
19.6744.04150.92---
PB Ratio
0.962.762.407.102.942.76
P/TBV Ratio
0.962.762.407.102.942.76
P/FCF Ratio
-96.27152.16---
P/OCF Ratio
-96.27152.16---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/FCF Ratio
-94.03152.28---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.22-0.010.080.020.03
Debt / FCF Ratio
--0.41---
Net Debt / Equity Ratio
0.18-0.02-0.110.05-0.18-0.22
Net Debt / EBITDA Ratio
-2.3310.67-0.301.121.76
Net Debt / FCF Ratio
--0.80-6.72-19.641.350.07
Quick Ratio
0.370.6817.200.377.876.49
Current Ratio
1.240.6817.210.468.196.69
Return on Equity (ROE)
3.04%6.19%3.03%-5.11%-8.77%-295.12%
Return on Assets (ROA)
-0.40%-0.58%-1.18%-9.62%-9.37%-3.70%
Return on Invested Capital (ROIC)
-0.67%-1.04%-2.09%-17.40%-19.41%-13.92%
Return on Capital Employed (ROCE)
-0.70%-1.00%-1.00%-15.60%-16.30%-13.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
5.08%2.27%0.66%-0.69%-3.16%-114.37%
FCF Yield
-1.04%0.66%-0.03%-4.57%-118.79%
Buyback Yield / Dilution
11.03%-121.94%-6.92%1.47%-1.71%-0.99%